Recipient and donor thrombophilia and the risk of portal venous thrombosis and hepatic artery thrombosis in liver recipients

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Ayala, Rosa ^a,c   Martínez López, Joaquín ^a,c   Cedena, Teresa ^a   Bustelos, Rosalía ^b   Jimenez, Carlos ^a,c   Moreno, Enrique ^a,c   Ribera, Carmen ^a,c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b Hospital Sureste (Arganda Del Rey)   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 8; CORTICOSTEROID; CYCLOSPORIN A; FIBRINOGEN; GENOMIC DNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROTEIN C; TACROLIMUS; F8 PROTEIN, HUMAN;

ADULT; AGED; ALLOGRAFT THROMBOSIS; ARTERY THROMBOSIS; ARTICLE; BLOOD CLOTTING TEST; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HEPATIC ARTERY THROMBOSIS; HIGH RISK POPULATION; HUMAN; LIVER GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OVERALL SURVIVAL; PORTAL VEIN THROMBOSIS; POSTOPERATIVE THROMBOSIS; PROTEIN BLOOD LEVEL; RELAPSE; RETROSPECTIVE STUDY; RISK FACTOR; SPAIN; THROMBOPHILIA; ADOLESCENT; BLOOD; CHILD; GENETICS; GRAFT SURVIVAL; HEPATIC ARTERY; INFANT; KAPLAN MEIER METHOD; LIVER TRANSPLANTATION; METABOLISM; MIDDLE AGED; PORTAL VEIN; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; THROMBOSIS;

ADOLESCENT; ADULT; ANTITHROMBINS; CHILD; CHILD, PRESCHOOL; FACTOR VIII; FEMALE; FIBRINOGEN; GRAFT SURVIVAL; HEPATIC ARTERY; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PORTAL VEIN; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTEIN C; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOPHILIA; THROMBOSIS; YOUNG ADULT;

EID: 82155168572     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-130     Document Type: Article

References (33)

1. Wozney P, Zajko AB, Bron KM, Point S, Starzl TE. Vascular complications after liver transplantation: a 5-year experience. AJR Am J Roentgenol 1986, 147(4):657-663. 3095891, 3529892.
2. Pinna AD, Smith CV, Furukawa H, Starzl TE, Fung JJ. Urgent revascularization of liver allografts after early hepatic artery thrombosis. Transplantation 1996, 62(11):1584-1587. 10.1097/00007890-199612150-00010, 3018871, 8970612.
3. Pastacaldi S, Teixeira R, Montalto P, Rolles K, Burroughs AK. Hepatic artery thrombosis after orthotopic liver transplantation: a review of nonsurgical causes. Liver Transpl 2001, 7(2):75-81. 10.1053/jlts.2001.22040, 11172388.
4. Dodd GD, Memel DS, Zajko AB, Baron RL, Santaguida LA. Hepatic artery stenosis and thrombosis in transplant recipients: Doppler diagnosis with resistive index and systolic acceleration time. Radiology 1994, 192(3):657-661.
5. Abbasoglu O, Levy MF, Testa G, Obiekwe S, Brkic BS, Jennings LW, Goldstein RM, Husberg BS, Gonwa TA, Klintmalm GB. Does intraoperative hepatic artery flow predict arterial complications after liver transplantation?. Transplantation 1998, 66(5):598-601. 10.1097/00007890-199809150-00008, 9753338.
6. Hirshfield G, Collier JD, Brown K, Taylor C, Frick T, Baglin TP, Alexander GJ. Donor factor V Leiden mutation and vascular thrombosis following liver transplantation. Liver Transpl Surg 1998, 4(1):58-61. 10.1002/lt.500040108, 9457968.
7. Dunn TB, Linden MA, Vercellotti GM, Gruessner RW. Factor V Leiden and hepatic artery thrombosis after liver transplantation. Clin Transplant 2006, 20(1):132-135. 10.1111/j.1399-0012.2005.00432.x, 16556168.
8. Stahl RL, Duncan A, Hooks MA, Henderson JM, Millikan WJ, Warren WD. A hypercoagulable state follows orthotopic liver transplantation. Hepatology 1990, 12(3 Pt 1):553-558.
9. Kassis J, Hirsh J, Podor TJ. Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type I plasminogen activator inhibitor biosynthesis. Blood 1992, 80(7):1758-1764.
10. Lisman T, Porte RJ. Hepatic artery thrombosis after liver transplantation: more than just a surgical complication?. Transpl Int 2009, 22(2):162-164. 10.1111/j.1432-2277.2008.00762.x, 18796001.
11. Bispo M, Marcelino P, Freire A, Martins A, Mourao L, Barroso E. High incidence of thrombotic complications early after liver transplantation for familial amyloidotic polyneuropathy. Transpl Int 2009, 22(2):165-171. 10.1111/j.1432-2277.2008.00737.x, 18699846.
12. Bekker J, Ploem S, de Jong KP. Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant 2009, 9(4):746-757. 10.1111/j.1600-6143.2008.02541.x, 19298450.
13. Bustelos R, Ayala R, Martinez J, Martin MA, Toledo T, Grande S, Garfia C, Moreno A, Perez B, Meneu JC, et al. Living donor liver transplantation: usefulness of hemostatic and prothrombotic screening in potential donors. Transplant Proc 2009, 41(9):3791-3795. 10.1016/j.transproceed.2009.06.214, 19917389.
14. Silva MA, Jambulingam PS, Gunson BK, Mayer D, Buckels JA, Mirza DF, Bramhall SR. Hepatic artery thrombosis following orthotopic liver transplantation: a 10-year experience from a single centre in the United Kingdom. Liver Transpl 2006, 12(1):146-151. 10.1002/lt.20566, 16382467.
15. Olthoff KM, Merion RM, Ghobrial RM, Abecassis MM, Fair JH, Fisher RA, Freise CE, Kam I, Pruett TL, Everhart JE, et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg 2005, 242(3):314-323. discussion 323-315, 1357740, 16135918.
16. Egesel T, Buyukasik Y, Dundar SV, Gurgey A, Kirazli S, Bayraktar Y. The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis. J Clin Gastroenterol 2000, 30(1):66-71. 10.1097/00004836-200001000-00013, 10636214.
17. Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, van Hattum J, Chamuleau RA, Adang RP, Vandenbroucke JP, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000, 96(7):2364-2368.
18. Primignani M, Martinelli I, Bucciarelli P, Battaglioli T, Reati R, Fabris F, Dell'era A, Pappalardo E, Mannucci PM. Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 2005, 41(3):603-608. 10.1002/hep.20591, 15726653.
19. Denninger MH, Chait Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Briere J, Valla D. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000, 31(3):587-591. 10.1002/hep.510310307, 10706547.
20. Foster PA, Varma RR. Phenotypic correction of activated protein C resistance following orthotopic liver transplantation. Blood Coagul Fibrinolysis 1996, 7(1):65-68. 10.1097/00001721-199601000-00008, 8845465.
21. Estelles A, Villa P, Mira Y, Vaya A, Segui R, Aznar J. Factor V Leiden in absence of activated protein C resistance after orthotopic liver transplantation in a patient without thrombosis but with familial thrombophilia. Haematologica 2000, 85(1):111-112.
22. Loew A, Jacob D, Neuhaus P, Riess H. Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation. Transplantation 2005, 79(10):1422-1427. 10.1097/01.TP.0000158021.66004.19, 15912114.
23. Camire RM, Kalafatis M, Simioni P, Girolami A, Tracy PB. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C. Blood 1998, 91(8):2818-2829.
24. Gould WR, Simioni P, Silveira JR, Tormene D, Kalafatis M, Tracy PB. Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactor. J Thromb Haemost 2005, 3(3):450-456. 10.1111/j.1538-7836.2005.01157.x, 15748232.
25. Gould WR, Silveira JR, Tracy PB. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va. J Biol Chem 2004, 279(4):2383-2393.
26. Sundaram SS, Alonso EM, Anand R. Outcomes after liver transplantation in young infants. J Pediatr Gastroenterol Nutr 2008, 47(4):486-492.
27. Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005, 294(14):1799-1809.
28. Lisman T, Caldwell SH, Burroughs AK, Northup PG, Senzolo M, Stravitz RT, Tripodi A, Trotter JF, Valla DC, Porte RJ. Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol 53(2):362-371.
29. Levitsky J, Freifeld A, Lyden E, Stoner J, Florescu D, Langnas A, Brian Stevens R, Hardiman P, Hill L, Kalil AC. Evaluation of the coagulation and inflammatory responses in solid organ transplant recipients and donors. Clin Transplant 2009, 23(6):943-950. 10.1111/j.1399-0012.2009.01038.x, 19624696.
30. Tripodi A, Primignani M, Chantarangkul V, Dell'Era A, Clerici M, de Franchis R, Colombo M, Mannucci PM. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 2009, 137(6):2105-2111. 10.1053/j.gastro.2009.08.045, 19706293.
31. Baruch Y, Neubauer K, Ritzel A, Wilfling T, Lorf T, Ramadori G. Von Willebrand gene expression in damaged human liver. Hepatogastroenterology 2004, 51(57):684-688.
32. Albornoz L, Alvarez D, Otaso JC, Gadano A, Salviu J, Gerona S, Sorroche P, Villamil A, Mastai R. Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels. J Hepatol 1999, 30(3):451-455. 10.1016/S0168-8278(99)80104-4, 10190728.
33. Zocco MA, Di Stasio E, De Cristofaro R, Novi M, Ainora ME, Ponziani F, Riccardi L, Lancellotti S, Santoliquido A, Flore R, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009, 51(4):682-689. 10.1016/j.jhep.2009.03.013, 19464747.